Adverum Biotechnologies
ADVM
ADVM
77 hedge funds and large institutions have $70M invested in Adverum Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $85.9M → $70M (-$15.9M)
45% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 29
59% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 27
Holders
77
Holding in Top 10
2
Calls
$1.9M
Puts
$13K
Top Buyers
| 1 | +$8.41M | |
| 2 | +$2.07M | |
| 3 | +$1.25M | |
| 4 |
NM
Newtyn Management
New York
|
+$1.24M |
| 5 |
Renaissance Technologies
New York
|
+$836K |
Top Sellers
| 1 | -$9.11M | |
| 2 | -$4.79M | |
| 3 | -$3.49M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.77M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.01M |